4//SEC Filing
Nicaise Claude 4
Accession 0001178913-23-001113
CIK 0001534248other
Filed
Mar 22, 8:00 PM ET
Accepted
Mar 23, 7:36 AM ET
Size
10.8 KB
Accession
0001178913-23-001113
Insider Transaction Report
Form 4
Nicaise Claude
Director
Transactions
- Award
Option to Purchase American Depositary Shares
2023-03-16+6,857→ 6,857 totalExercise: $1.62Exp: 2033-03-21→ American Depositary Shares (6,857 underlying) - Award
Option to Purchase American Depositary Shares
2023-03-16+6,820→ 6,820 totalExercise: $3.53Exp: 2032-03-07→ American Depositary Shares (6,820 underlying) - Award
Option to Purchase American Depositary Shares
2023-03-16+11,884→ 11,884 totalExercise: $27.26Exp: 2031-04-19→ American Depositary Shares (11,884 underlying)
Footnotes (5)
- [F1]These options were granted as per the annual grant of options to directors. These options vest and become exercisable in their entirety on March 16, 2024, subject to the Reporting Person's continued service.
- [F2]Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
- [F3]No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
- [F4]These options vested and became exercisable in their entirety on March 16, 2023. These options were granted as per the annual grant of options to directors.
- [F5]These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service.
Documents
Issuer
Chemomab Therapeutics Ltd.
CIK 0001534248
Entity typeother
Related Parties
1- filerCIK 0001644162
Filing Metadata
- Form type
- 4
- Filed
- Mar 22, 8:00 PM ET
- Accepted
- Mar 23, 7:36 AM ET
- Size
- 10.8 KB